XENON PHARMACEUTICALS INC shareholders Q3 2023

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 184 filers reported holding XENON PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 2.73 and the average weighting 0.4%.

XENON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
BRAIDWELL LP 2,103,396$71,852,0072.27%
Nicholas Investment Partners, LP 854,447$29,187,9102.18%
Logos Global Management LP 450,000$15,372,0002.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,513,005$154,164,2512.00%
First Light Asset Management, LLC 602,070$20,566,7111.95%
Tri Locum Partners LP 171,755$5,867,1511.88%
BVF INC/IL 1,827,958$62,443,0451.68%
Connacht Asset Management LP 8,204$280,2491.66%
Parkman Healthcare Partners LLC 216,644$7,400,5591.36%
Ghost Tree Capital, LLC 98,951$3,380,1661.11%
External links

This page lists XENON PHARMACEUTICALS INC's shareholders in Q3 2023. To view XENON PHARMACEUTICALS INC's shareholder history, click here.